Late Gastrointestinal Toxicity After Dose-Escalated Conformal Radiotherapy for Early Prostate Cancer: Results From the UK Medical Research Council RT01 Trial (ISRCTN47772397)

PURPOSE: In men with localized prostate cancer, dose-escalated conformal radiotherapy (CFRT) improves efficacy outcomes at the cost of increased toxicity. We present a detailed analysis to provide further information about the incidence and prevalence of late gastrointestinal side effects. METHODS A...

Descripción completa

Detalles Bibliográficos
Autores principales: Syndikus, Isabel, Morgan, Rachel C., Sydes, Matthew R., Graham, John D., Dearnaley, David P.
Formato: Texto
Lenguaje:English
Publicado: Elsevier Science Inc 2010
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937212/
https://www.ncbi.nlm.nih.gov/pubmed/19836155
http://dx.doi.org/10.1016/j.ijrobp.2009.05.052

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2937212/
https://www.ncbi.nlm.nih.gov/pubmed/19836155
http://dx.doi.org/10.1016/j.ijrobp.2009.05.052

Ejemplares similares